Pelican claims it expands deep freeze range to meet Covid needs
PELICAN BioThermal, a major in temperature controlled packaging, has announced deep frozen temperature controlled packaging of minus 80 degrees Celsius to minus 20 degrees Celsius - within of Covid vaccine shipment needs
PELICAN BioThermal, a major in temperature controlled packaging, has announced deep frozen temperature controlled packaging of minus 80 degrees Celsius to minus 20 degrees Celsius - within of Covid vaccine shipment needs.
The Minnesota company said new deep freeze solutions are suitable for short-term vaccine storage, redirect courier transport of vaccines from freezer farm hubs to immunisation locations and daily vaccine replenishment to remote and rural areas.
'The new offerings help meet the growing need for increased deep frozen temperature ranges and payload capacities as pharmaceutical companies and their supply chains prepare to bring Covid-19 vaccines and therapeutics to market,' said the company statement.
Pelican BioThermal has long offered its reusable Credo Cube in minus 20 degree and minus 50 degree Celsius temperatures. Through innovation and adaptation, many of the company's product lines now include a variety of frozen options that cover temperatures of minus 20, minus 35, minus 50 and minus 80 degrees Celsius, it said.
'Our engineering team matched this urgency to ensure they have the correct temperature controlled packaging to meet them where they're at in drug development for the pandemic recovery, from discovery to distribution,' said Pelican BioThermal vice president Greg Wheatley.
Pelican's deep frozen products use phase change material (PCM) and dry ice systems to provide frozen payload protection with durations from 72 hours to 144+ hours. Payload capacities range from 1 to 96 liters for parcel shippers and 371 to 1,686 liters for pallet shippers.